Institute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research; a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Feodor-Lynen-Str. 7, 30625 Hannover, Germany.
Org Lett. 2019 Sep 6;21(17):6966-6971. doi: 10.1021/acs.orglett.9b02555. Epub 2019 Aug 21.
The Simmons-Smith-Furukawa reaction was used to generate 4'/5'-spirocyclopropanated uridine analogs from electron-rich exocyclic enol esters. During synthesis, the native hydroxylation pattern of the nucleoside is preserved and offers the possibility for a late stage 5'-phosphorylation at the spirocyclopropanol moiety. All synthesized spirocyclopropanated uridine derivatives, including the corresponding 5'-monophosphate (cpUMP), were evaluated with respect to their antiviral activity in an HRSV assay showing moderate, but promising activity.
西姆斯-史密斯-古川反应被用来从富电子的环外烯醇酯中生成 4'/5'-螺环丙醇化尿苷类似物。在合成过程中,核苷的固有羟基化模式得以保留,并为螺环丙醇部分的后期 5'-磷酸化提供了可能。所有合成的螺环丙醇化尿苷衍生物,包括相应的 5'-单磷酸酯(cpUMP),都在 HRSV 测定中进行了抗病毒活性评估,结果显示出中等但有前途的活性。